Citations (27)
Keep up to date with the latest research on this topic with citation updates for this article.
Articles from other publishers (27)
E. V. Grakova, K. V. Kopieva, A. M. Gusakova, A. V. Smorgon, A. N. Maltseva, A. V. Mochula, A. V. Svarovskaya & K. V. Zavadovsky. (2023) Significance of catestatin in the pathogenesis of heart failure with preserved ejection fraction in patients with non-obstructive coronary artery disease. Russian Journal of Cardiology 28:11, pages 5568.
Crossref
Crossref
Ewa Zalewska, Piotr Kmieć, Jakub Sobolewski, Andrzej Koprowski & Krzysztof Sworczak. (2023) Low catestatin as a risk factor for cardiovascular disease – assessment in patients with adrenal incidentalomas. Frontiers in Endocrinology 14.
Crossref
Crossref
Łukasz Wołowiec, Joanna Banach, Jacek Budzyński, Anna Wołowiec, Mariusz Kozakiewicz, Maciej Bieliński, Albert Jaśniak, Agata Olejarczyk & Grzegorz Grześk. (2023) Prognostic Value of Plasma Catestatin Concentration in Patients with Heart Failure with Reduced Ejection Fraction in Two-Year Follow-Up. Journal of Clinical Medicine 12:13, pages 4208.
Crossref
Crossref
Aliye Çelikkol, Aykut Demirkıran, Cihan Aydın, Aydın Akyüz, Mustafa Kaplangöray, Ahsen Yılmaz, Muhammed Mucip Efe & Savaş Güzel. (2023) Serum chromogranin A levels are associated with the SYNTAX score in coronary artery disease. Revista da Associação Médica Brasileira 69:4.
Crossref
Crossref
Iyyapu Krishna Mohan, K.S.S. Sai Baba, Rohit Iyyapu, Sunitha Thirumalasetty & O. Sai Satish. 2023.
205
248
.
Amina M. Alieva, Natalia V. Teplova, Elena V. Reznik, Olga A. Ettinger, Rashad A. Faradzhov, Elvira A. Khachirova, Irina V. Kovtiukh, Irina A. Kotikova, Diana A. Sysoeva, Il'dar R. Bigushev & Igor G. Nikitin. (2022) Catestanin – a promising biological marker for heart failure: A review. Consilium Medicum 24:10, pages 726-731.
Crossref
Crossref
Ewa Zalewska, Piotr Kmieć & Krzysztof Sworczak. (2022) Role of Catestatin in the Cardiovascular System and Metabolic Disorders. Frontiers in Cardiovascular Medicine 9.
Crossref
Crossref
O. Pankova. (2022) The potential of catestatin in the diagnostics of cardiovascular diseases: current data and perspectives. Shidnoevropejskij zurnal vnutrisnoi ta simejnoi medicini 2022:2, pages 43-48.
Crossref
Crossref
Josko Bozic, Marko Kumric, Tina Ticinovic Kurir, Hrvoje Urlic, Dinko Martinovic, Marino Vilovic, Nada Tomasovic Mrcela & Josip A. Borovac. (2021) Catestatin as a Biomarker of Cardiovascular Diseases: A Clinical Perspective. Biomedicines 9:12, pages 1757.
Crossref
Crossref
Yu. V. Meshcheryakov, I. V. Gubareva, E. Yu. Gubareva & A. Yu. Alekseeva. (2021) Role of catestatin in development and decompensation of heart failure: a literature review. Russian Journal of Cardiology 26:3S, pages 4492.
Crossref
Crossref
Katja Höglund, Jens Häggström, Odd Viking Höglund, Mats Stridsberg, Anna Tidholm & Ingrid Ljungvall. (2020) The chromogranin A-derived peptides catestatin and vasostatin in dogs with myxomatous mitral valve disease. Acta Veterinaria Scandinavica 62:1.
Crossref
Crossref
Łukasz Wołowiec, Daniel Rogowicz, Joanna Banach, Wojciech Gilewski, Władysław Sinkiewicz & Grzegorz Grześk. (2020) Catestatin as a New Prognostic Marker in Stable Patients with Heart Failure with Reduced Ejection Fraction in Two-Year Follow-Up. Disease Markers 2020, pages 1-10.
Crossref
Crossref
Josip Anđelo Borovac, Domenico D'Amario, Josko Bozic & Duska Glavas. (2020) Sympathetic nervous system activation and heart failure: Current state of evidence and the pathophysiology in the light of novel biomarkers. World Journal of Cardiology 12:8, pages 373-408.
Crossref
Crossref
Song-Yun Chu, Fen Peng, Jie Wang, Lin Liu, Lei Meng, Jing Zhao, Xiao-Ning Han & Wen-Hui Ding. (2020) Catestatin in defense of oxidative-stress-induced apoptosis: A novel mechanism by activating the beta2 adrenergic receptor and PKB/Akt pathway in ischemic-reperfused myocardium. Peptides 123, pages 170200.
Crossref
Crossref
Josip A. Borovac, Duska Glavas, Zora Susilovic Grabovac, Daniela Supe Domic, Domenico D’Amario & Josko Bozic. (2019) Catestatin in Acutely Decompensated Heart Failure Patients: Insights from the CATSTAT-HF Study. Journal of Clinical Medicine 8:8, pages 1132.
Crossref
Crossref
E. Yu. Gubareva, N. N. KryukovI. V. Gubareva. (2018) CATESTATIN AS A NOVEL MARKER OF CARDIOVASCULAR RISK IN SYSTEMIC HYPERTENSION. Russian Journal of Cardiology:4, pages 111-116.
Crossref
Crossref
Thanikul Srithunyarat, Ragnvi Hagman, Odd V. H?glund, Ulf Olsson, Mats Stridsberg, Supranee Jitpean, Anne-Sofie Lagerstedt & Ann Pettersson. (2017) Catestatin and vasostatin concentrations in healthy dogs. Acta Veterinaria Scandinavica 59:1.
Crossref
Crossref
Anett H. Ottesen, Geir Christensen, Torbjørn Omland & Helge Røsjø. (2017) Glycosylated Chromogranin A: Potential Role in the Pathogenesis of Heart Failure. Current Heart Failure Reports 14:6, pages 478-488.
Crossref
Crossref
Josef Troger, Markus Theurl, Rudolf Kirchmair, Teresa Pasqua, Bruno Tota, Tommaso Angelone, Maria C. Cerra, Yvonne Nowosielski, Raphaela Mätzler, Jasmin Troger, Jaur R. Gayen, Vance Trudeau, Angelo Corti & Karen B. Helle. (2017) Granin-derived peptides. Progress in Neurobiology 154, pages 37-61.
Crossref
Crossref
Dan Zhu, Hong Xie, Xinyu Wang, Ying Liang, Haiyi Yu & Wei Gao. (2017) Catestatin-A Novel Predictor of Left Ventricular Remodeling After Acute Myocardial Infarction. Scientific Reports 7:1.
Crossref
Crossref
Anett Hellebø OttesenCathrine R. CarlsonWilliam E. LouchMai Britt DahlRagnhild A. SandbuRune Forstrøm JohansenHilde JarstadmarkenMagnar BjøråsArne Didrik HøisethJon BrynildsenIvar SjaastadMats StridsbergTorbjørn OmlandGeir ChristensenHelge Røsjø. (2017) Glycosylated Chromogranin A in Heart Failure. Circulation: Heart Failure 10:2.
Crossref
Crossref
Wen Qi Pan, Yu Hu He, Qian Su, Jie Yang, Yue Hua Fang, Feng Hua Ding, Xiao Xiang Yan, Zhu Hui Liu, Xiao Qun Wang, Ke Yang, Rui Yan Zhang, Wei Feng Shen, Feng Ru Zhang & Lin Lu. (2016) Association of decreased serum vasostatin-2 level with ischemic chronic heart failure and with MACE in 3-year follow-up: Vasostatin-2 prevents heart failure in myocardial infarction rats. International Journal of Cardiology 221, pages 1-11.
Crossref
Crossref
Yilin Zhao & Dan Zhu. (2016) Potential applications of catestatin in cardiovascular diseases. Biomarkers in Medicine 10:8, pages 877-888.
Crossref
Crossref
Feng Liao, Yang Zheng, Junyan Cai, Jinghui Fan, Jing Wang, Jichun Yang, Qinghua Cui, Guoheng Xu, Chaoshu Tang & Bin Geng. (2015) Catestatin attenuates endoplasmic reticulum induced cell apoptosis by activation type 2 muscarinic acetylcholine receptor in cardiac ischemia/reperfusion. Scientific Reports 5:1.
Crossref
Crossref
Dan Zhu, Hong Xie, Xinyu Wang, Ying Liang, Haiyi Yu & Wei Gao. (2015) Correlation of Plasma Catestatin Level and the Prognosis of Patients with Acute Myocardial Infarction. PLOS ONE 10:4, pages e0122993.
Crossref
Crossref
Jens P GoetzeUrban Alehagen, Allan Flyvbjerg & Jens F Rehfeld. (2014) Chromogranin A as a biomarker in cardiovascular disease. Biomarkers in Medicine 8:1, pages 133-140.
Crossref
Crossref
Jens P Goetze, Urban Alehagen, Allan Flyvbjerg & Jens F Rehfeld. (2013) Making sense of chromogranin A in heart disease. The Lancet Diabetes & Endocrinology 1:1, pages 7-8.
Crossref
Crossref